Navigation Links
BioPharma Institute Launches 5 Top U.S. Pharmaceutical & Clinical Research Industry Regulatory Compliance Courses as Parent Company Celebrates 20th Anniversary
Date:9/21/2017

Today, BioPharma Institute, a leading training platform for highly-regulated pharmaceutical and clinical research sector professionals, has announced the addition of 5 new courses to its prospectus. These include the eagerly-awaited Regulation 21 CFR Part 11 training - Compliance with Regulation 21 CFR Part 11 on Electronic Records and Electronic Signatures (Part 11 of Title 21 of the U.S. Code of Federal Regulations for computer systems in FDA-regulated environments). The Institute’s other new courses include Introduction to Drug Safety and Pharmacovigilance, Risk Management Planning for Medicinal Products, How to Gain Approval to Market a Generic Drug in the U.S., and How to Gain Approval for Clinical Trials in the USA. These new courses join the extensive list of programs training on good manufacturing practices (GMP), good laboratory practices (GLP), and good clinical practices (GCP).

Providing many world-class training programs and courses, the BioPharma Institute is trusted by thousands of highly skilled biopharmaceutical industry professionals working in FORTUNE 500 and other corporations in the U.S., plus 10 other countries worldwide. Additionally, Continuing Professional Development (CPD) points for many of its courses are recognized by the distinguished Faculty of Pharmaceutical Medicine of the Royal Colleges of Physicians of the United Kingdom. "We're delighted with the addition of 5 courses to an already extensive list of 100+ regulatory and compliance programs," asserted Algis Rajeckas, Ph.D., Director of Marketing at the BioPharma Institute. “Given our history, our aim is to continue to exceed the expectations of biopharmaceutical and clinic research professionals."

With headquarters in Paramus, New Jersey, the BioPharma Institute, a division of GeneTree, Inc. (celebrating its 20th anniversary), was founded in 2003 to provide industry-leading training solutions for professionals that are convenient, efficient, and effective for training those working in the highly regulated pharmaceutical, biotechnology, clinical research, and healthcare industries. "There's a tremendous range of courses available concentrating on regulatory affairs, as well as performing good manufacturing, clinical, and laboratory practices for industry professionals," explained, Fardad Gharebaghi, Commercial Director, LeoPink (a BioPharma Institute Content Partner). "The BioPharma Institute stands out as a premier training portal for professionals and corporations.”

Content-rich online training programs, including automated tracking systems and managed training records, have become a hallmark of the BioPharma Institute’s advanced e-learning certification classes for companies and employees. Its goal is to constantly update and offer the finest regulatory and compliance training course options in a state-of-the-art e-learning environment. "It's an honor to serve the on-going regulatory training requirements of small to mid-sized clinical research organizations, drug manufacturers, contractors, and professionals seeking to advance rewarding careers within these important sectors," expressed, Terry Carmichael, Managing Director and Founder of GeneTree, Inc. "In the past 14 years since launching the BioPharma Institute, we provided training to customers in a total of 11 countries, across 3 continents. We look forward to the future growth of the BioPharma Institute and all of our online training participants.”

About BioPharma Institute:
Since 2003, BioPharma Institute, a division of GeneTree, Inc., established in 1997, has been a leading provider of excellence in regulatory training for thousands of professionals and corporations seeking to excel in their industries. From its base in Paramus, New Jersey, BioPharma Institute offers convenient, efficient, and effective training solutions for those working in the highly regulated pharmaceutical, clinical research, biotechnology, and healthcare industries. Trusted for over 14 years, BioPharma Institute has aggregated a comprehensive range of web-based courses, books, live and recorded seminars, and other powerful training tools. Discover the future of e-learning today by visiting biopharmainstitute.com.

Read the full story at http://www.prweb.com/releases/2017/09/prweb14693587.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. VetStem Biopharma CEO and Founder, Dr. Bob Harman, Interviewed in New Book "Stem Cell Therapy: A Rising Tide"
2. LumaCyte joins The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL)
3. VetStem Biopharma Regenerative Cell Therapy has been Used on over 13,000 Animals
4. Bioquark Inc. and Lakmus LLC Announce Research Collaboration to Study Novel Biopharmaceuticals for Healthy Longevity Enhancement
5. Biotech Stocks Under Scanner -- Biostage, Keryx Biopharma, Kite Pharma, and ZIOPHARM Oncology
6. PDL BioPharma to Hold Annual Meeting of Stockholders on June 9, 2017
7. Ipsen Biopharmaceuticals Joins National Pharmaceutical Council
8. Biotech Stocks Under Scanner -- BioDelivery Sciences, Sage Therapeutics, Benitec Biopharma, and OncoGenex Pharma
9. Richard Peterson Joins Sienna Biopharmaceuticals As Chief Financial Officer
10. Array BioPharma Provides NEMO Update
11. Catalent Executives to Present on Clinical Trial Supply Management and Optimizing Product Development at Upcoming BioPharma Asia Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/9/2017)... , Oct. 9, 2017  BioTech Holdings ... mechanism by which its ProCell stem cell therapy ... limb ischemia.  The Company, demonstrated that treatment with ... of limbs saved as compared to standard bone ... molecule HGF resulted in reduction of therapeutic effect.  ...
(Date:10/9/2017)... Charlotte, N.C. (PRWEB) , ... October 09, 2017 , ... ... Purple announced Dr. Christopher Stubbs, a professor in Harvard University’s Departments of Physics and ... Dr. Stubbs was a member of the winning team for the 2015 Breakthrough Prize ...
(Date:10/9/2017)... Antonio, Texas (PRWEB) , ... ... ... new study published on October 5, 2017, in the medical journal, Epilepsia, ... equivalence with the gold standard, video EEG, in detecting generalized tonic-clonic seizures ...
(Date:10/7/2017)... ... October 06, 2017 , ... ... its ProxiMeta™ Hi-C metagenome deconvolution product, featuring the first commercially available Hi-C ... software to perform Hi-C metagenome deconvolution using their own facilities, supplementing the ...
Breaking Biology Technology:
(Date:4/13/2017)... MONICA, Calif. , April 13, 2017 ... New York will feature emerging and evolving ... Summits. Both Innovation Summits will run alongside the expo ... of speaker sessions, panels and demonstrations focused on trending ... coast,s largest advanced design and manufacturing event will take ...
(Date:4/11/2017)... April 11, 2017 NXT-ID, Inc. (NASDAQ: ... company, announces the appointment of independent Directors Mr. Robin ... its Board of Directors, furthering the company,s corporate governance and ... Gino Pereira ... look forward to their guidance and benefiting from their considerable ...
(Date:4/4/2017)... --  EyeLock LLC , a leader of iris-based identity ... and Trademark Office (USPTO) has issued U.S. Patent No. ... iris image with a face image acquired in sequence ... th issued patent. "The issuance ... multi-modal biometric capabilities that have recently come to market ...
Breaking Biology News(10 mins):